Achmea Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.2M |
| 2 |
Procter & Gamble
PG
|
+$10.8M |
| 3 |
Comcast
CMCSA
|
+$9.96M |
| 4 |
ExxonMobil
XOM
|
+$9.56M |
| 5 |
Walt Disney
DIS
|
+$9.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$22.3M |
| 2 |
UnitedHealth
UNH
|
+$11.8M |
| 3 |
TE Connectivity
TEL
|
+$11.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$11.3M |
| 5 |
Cigna
CI
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.1% |
| 2 | Healthcare | 16.95% |
| 3 | Financials | 14.06% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Communication Services | 10.34% |
Similar funds
Achmea Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Achmea Investment Management held 514 positions worth $2.16B, down 18% from $2.64B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Achmea Investment Management withdrew a net $136M in Q4 2018, closing 80 positions and reducing 115 holdings. Its most notable exit was Accenture, an estimated $22.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Achmea Investment Management opened a new position in lululemon athletica worth $2.28M.
- Achmea Investment Management's largest Q4 2018 buy was lululemon athletica: 18,763 shares worth $2.28M.
- Achmea Investment Management added most to Merck in Q4 2018, an estimated $11.2M increase.
- Achmea Investment Management's biggest Q4 2018 reduction was UnitedHealth, cutting an estimated $11.8M.
- Achmea Investment Management fully exited Accenture in Q4 2018, selling an estimated $22.3M.
- Achmea Investment Management's ten largest holdings make up 23% of its $2.16B portfolio in Q4 2018.
- Achmea Investment Management opened 36 new positions and closed 80 in Q4 2018.
- Achmea Investment Management's portfolio value fell 18% quarter-over-quarter to $2.16B.
Based on Achmea Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.